GENE ONLINE|News &
Opinion
Blog

Incyte Corporation
Incyte’s Zynyz Secures FDA Approval for Treating a Rare and Aggressive Skin Cancer
2023-03-23
Incyte’s Rare Cancer Drug Snags Second FDA Approval
2022-08-29
Syndax, Incyte Sign $602 Million Collab to Advance Monoclonal Antibody
2021-09-29
FDA Approves Incyte’s Jakafi for Chronic Graft-Versus-Host Disease
2021-09-23
China’s InnoCare, Incyte Enter Collaboration And License Deal for Monoclonal Antibody in Greater China
2021-08-18
Another Checkpoint Inhibitor Set to Make Market Appearance as FDA Grants Priority Review
2021-01-25
Novartis Announces Failure of Ruxolitinib Trial in Severe COVID-19
2020-12-18
ASH2020: Incyte Presents Positive Phase 3 Data for cGVHD Drug, Ruxolitinib
2020-12-06
Lilly, Incyte Gaining Ground in the Fight against Alopecia Areata
2020-11-01
Eli Lilly Gets FDA Breakthrough Status for Alopecia Drug
2020-03-17
LATEST
Innovative Cellular Mapping of BRCA-Related Breast Cancer Findings Reveals Novel Therapeutic Targets
2024-03-29
Previewing AACR 2024 With Select Pre-Meeting Highlights
2024-03-28
Roche Delivering on Malaria Screening Solutions for Blood Donation
2024-03-28
Innovating Cancer Treatment: The Role of ADC Technology at Nona Biosciences
2024-03-28
BIO CHINA 2024 Brings Biotech Experts and Industry Elites Together for Innovation
2024-03-27
Galderma’s Strong European IPO Debut
2024-03-26
Markets and Mergers: Boston Scientific and Axonics Shake Hands on Deal
2024-03-25
EVENT
2024-04-06
Biotech Innovation Funding Networking
Los Angeles, USA
Scroll to Top